CTRI/2018/04/013084
Completed
未知
Experimental and clinical evaluation of standardized Krishnavajrabhraka Bhasma for its rasayan karma in Shwas vyadhi
Department of Indian System of Medicine Homoepathy AYUSH0 sites41 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Chronic bronchial Asthma
- Sponsor
- Department of Indian System of Medicine Homoepathy AYUSH
- Enrollment
- 41
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •I Ayurvedic parameters
- •Patients presenting with signs and symptoms of Tamak Shwas for equal to and more than one year as described in Ayurvedic texts.
- •Patients presenting with 3 or more of the following symptoms\-
- •i. Peenasii. Ghurghurak
- •iii. Aasya Udhvanasa iv. Kantha Udhvansav.Vak Kricchratavi. Lalat Sweda
- •vii. Parshvagrahaviii. Ushnabhiprayataix. Aasya Shushkata x. Vepathu xi. Aruchixii. Annadvesh
- •II Modern medicine parameters
- •Patients with bronchial asthma categorised as
- •mild intermittent
- •mild persistant
Exclusion Criteria
- •I Ayurvedic Parameters
- •Patients in whom â??Shwasâ?? is present as a Upadrava, Lakshan , Udarka, Poorvaroop and Arishta lakshan of other disease.
- •Patients in whom the onset of disease is less than one year
- •Patients with Shwas caused due to fatal injury of Urasthita Marma (Stanmool, Stanrohit, Aapalaap, Aapsthambh).
- •Patients with critical condition of Shwas.
- •Patients with Shwas which requires Shodhan such as Virechan or Vaman for therapeutic use
- •II Modern medicine parameters
- •Cases with co\-existing pulmonary conditions.
- •Acute respiratory tract infection.
- •Requiring oral steroids.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Evaluation of a protocol for the reduction of doses in patients with rheumatoid arthritis (RA) in clinical remission in treatment with biological therapiesEvaluation of the clinical utility of a standardized protocol of strategies for the reduction of doses in patients with rheumatoid arthritis in clinical remission at treatment with biologic therapiesTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2012-004482-40-ESFRANCISCO J. BLANCO GARCÍA
Not yet recruiting
Phase 1
Research on standardization and clinical evaluation of Traditional Chinese Medicine press needle combined with auricular point pressing to prevent and control myopia in children and adolescentsITMCTR2100005080Eye Hospital China Academy of Chinese Medical Science
Not yet recruiting
Not Applicable
Clinical study of standardized Ashwagandha in healthy male volunteersCTRI/2023/04/051632Pharmanza Herbal Pvt. Ltd.
Not yet recruiting
Phase 1
Standardized research and clinical efficacy evaluation of treatment of interstitial lung disease based on lung-collateral theoryinterstitial lung diseaseITMCTR2000003785Shanghai Pulmonary Hospital
Active, not recruiting
Phase 3
Evaluation of the efficiency of photobiomodulation in the prevention of oral mucositis? in chemotherapy-treated cancer patientsPrevention of oral mucositis? in chemotherapy-treated cancer patientsOral HealthISRCTN70634383Damascus University45